U.S. markets close in 3 hours 25 minutes

Precipio, Inc. (PRPO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
6.02+0.28 (+4.88%)
As of 12:24PM EDT. Market open.

Precipio, Inc.

4 Science Park
3rd Floor
New Haven, CT 06511
United States
203 787 7888

IndustryDiagnostics & Research
Full Time Employees53

Key Executives

NameTitlePayExercisedYear Born
Mr. Ilan DanieliFounder, Pres, CEO & Director324.1kN/A1972
Dr. Ayman A. Mohamed M.D.Chief Technology Officer234.1kN/A1985
Mr. Matthew GageInterim Chief Financial OfficerN/AN/A1967
Mr. Ahmed Zaki SabetChief Operating OfficerN/AN/A1987
Ms. Miri Chiko-RadomskiChief Legal Counsel & People OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

Corporate Governance

Precipio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.